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Nature killer (NK) cells are important lymphocytes of the innate immune system, well known for their pivotal roles in immune
surveillance and defense against tumor and virus-infected cells. Current studies have revealed that NK cells are not a homogeneous
population, but instead consist of distinct subsets with diverse characteristics. As an organ with predominant innate immunity, the
liver is enriched with NK cells, among which two distinct NK cell subsets have recently been identified: conventional NK (cNK)
cells and tissue-resident NK (trNK) cells. Liver trNK cells are markedly different from cNK cells in many aspects, representing a
new lineage of innate lymphoid cell (ILC) family. Here, we summarize the phenotypic and functional features of liver trNK cells,
and review current knowledge regarding developmental pathway of liver trNK cells. We also overview recent advances in human
liver trNK cells and discuss the striking shared hallmarks of trNK cells in different tissues.
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INTRODUCTION
Natural killer (NK) cells are the prototype member of innate
lymphoid cell (ILC) family (Spits and Di Santo, 2011). Since
their discovery in the 1970s, many studies have shown the im-
portance of NK cells in host defense against microbial infec-
tions and tumors (Dahlberg et al., 2015; Eissens et al., 2014;
Sun et al., 2015). In particular, most of previous studies on
NK cells have focused on mouse splenic and human periph-
eral blood NK cells, which are circulating and referred to as
conventional NK (cNK) cells (Sojka et al., 2014b). However,
NK cells have recently been attracting attention for their het-
erogeneous subsets based on tissue distribution (Rajagopalan,
2014; Shi et al., 2011).
The liver is a unique organ with predominant innate immu-
*Corresponding author (email: huipeng@mail.ustc.edu.cn)
nity, containing a large number of innate immune cells, such
as Kupffer cells, NK cells, NKT cells and γδ T cells (Gao et
al., 2008; Ma et al., 2015). Earlier studies have indicated that
hepatic NK cells were phenotypically different from splenic
NK cells, and these findings were initially attributed to the
abundant presence of cNK-cell developmental intermediates
(Kim et al., 2002; Takeda et al., 2005). Until recently, we and
others have showed that mouse liver NK cells can be divided
into two distinct subsets based on CD49a and DX5 expres-
sion: One subset characterized as CD49a−DX5+ is cNK cells
as it resembles splenic NK cells and circulates in the blood
(Peng et al., 2013; Sojka et al., 2014a). Another subset is tis-
sue-resident NK (trNK) cells and characterized by the specific
CD49a+DX5− phenotype, residing in the liver sinusoid blood
and conferring memory-like responses in contact hypersensi-
tivity (CHS) models (Peng et al., 2013). Subsequent studies
further revealed that liver trNK cells and cNK cells require
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different transcription factors for their development, thus rep-
resenting separate developmental lineages (Constantinides et
al., 2014; Daussy et al., 2014; Klose et al., 2014; Mackay et
al., 2016).
LOCATION AND ORIGINS OF LIVER TRNK
CELLS
The liver has two afferent vascular supplies, the portal vein
and hepatic artery, the blood of which mixes together in the
hepatic sinusoids (Jenne and Kubes, 2013; Racanelli and
Rehermann, 2006). CD49a+DX5− NK cells reside neither
in afferent nor in efferent blood of the liver; instead, they
are present in the sinusoids (Peng et al., 2013). In line with
these observations, analysis of parabiotic mice, which allow
sharing of the blood circulation through joint circulation,
revealed that liver CD49a+DX5− NK cells were mostly host
derived, confirming their tissue-resident feature (Peng et al.,
2013; Sojka et al., 2014b); however, liver CD49a−DX5+ NK
cells are derived from both host and the other parabiont.
Notably, liver trNK cells from mice in parabiosis for more
than three months still remained host-derived, suggesting
that liver trNK cells are not continuously replaced by bone
marrow (BM)-derived precursors (Gasteiger et al., 2015).
Consistently, in lethally irradiated mice that were trans-
planted with BM cells, liver trNK cells were significantly
reduced as compared with those in normal mice (Peng et al.,
2013). These findings raised the question of whether liver
trNK cells are locally renewed (Yokoyama et al., 2013).
Liver is a major hematopoietic site during fetal life and
maintains a few hematopoietic stem cells in adults (Crosbie et
al., 1999; Kotton et al., 2005; Orkin and Zon, 2008; Taniguchi
et al., 1996; Wang et al., 2012). Our previous study has in-
dicated that hematopoietic progenitors in adult liver can gen-
erate liver trNK cells, which is likely one source for the re-
plenishment of liver trNK cells (Peng et al., 2013). It is also
plausible that liver trNK cells arising from the fetal period
may locally self-renew and persist for life time, akin to tis-
sue-resident macrophages (Figure 1).
DEVELOPMENT OF LIVER TRNK CELLS
Regarding cell development, liver trNK cells share common
features with cNK cells but can be distinguished (Peng and
Tian, 2015). Similar to T cells and B cells, trNK and cNK
cells develop from common lymphoid progenitors (CLPs).
Committed ILC progenitors, which have the potential to give
rise to all ILC lineages but not other hematopoietic lineages,
are downstream of CLPs. A progenitor subset characterized
as CXCR6+Flt3−α4β7+ CLPs (known as CXCR6+ αLPs) has
been reported to give rise to cNK cells, trNK cells and other
ILC lineages, but not T and B cells (Yu et al., 2014). How-
ever, CXCR6+ αLPs are very rare, and only 2.5% of them can
Figure 1   Possible origins of trNK cells in the adult liver under homeosta-
sis. Liver trNK cells emerge during fetal life and persist with age. It is
possible that the self-renewal of fetal liver trNK cells may contribute to the
adult liver trNK-cell pool. Since the fetal liver also functions as an impor-
tant haematopoetic organ, an alternative possible origin of trNK cells isthe
intraheaptic progenitors, such as hematopoietic stem cells (HSCs), which are
maintained in the adult liver and can persistently give rise to trNK cells. In
contrast to the enigmatic origin of trNK cells, the generation of cNK cells
and their development majorly take place in the bone marrow (BM).
generate all four ILC lineages at the clonal level (Yu et al.,
2014). More recently, Lin− TCF-1+Thy-1−IL-7Rαlo-neg cells
have been found to give rise to all ILC lineages (Figure 2),
and thus termed as early ILC progenitors (EILPs) (Yang et
al., 2015).
A branching point between cNK cells and other ILC sub-
sets has been demonstrated. Lin−Id2+IL-7Rα+CD25−α4β7+
cells, known as CHILPs, have the potential to give rise to all
helper-like ILC lineages, including liver trNK cells, but could
not give rise to cNK cells or T and B cells (Klose et al., 2014).
Moreover, a subset of progenitors marked by PLZF expres-
sion represents a more restricted-development potential com-
pared to CHILPs, since it could develop into liver trNK cells,
ILC2s, ILC3s, but not cNK and LTi cells (Constantinides et
al., 2014). These findings suggest liver trNK cells and cNK
cells represent separate developmental lineages.
Remarkable progress has recently been made in the recog-
nition of transcription factors that control the development of
NK cell subsets at early stages (Zook and Kee, 2016). For ex-
ample, TCF1 and NFIL3 are responsible for the generation of
ILC progenitors, therefore affecting the development of trNK
cells, cNK cells as well as other mature ILC subsets (Geiger
et al., 2014; Seillet et al., 2014b; Yang et al., 2015; Yu et al.,
2014). Notably, in NFIL3-deficient mice, CD49a+DX5− trNK
cells are reduced but still predominant in the liver, suggesting
the existence of NFIL3-independent trNK cells (Crotta et al.,
2014;  Seillet et al., 2014a;  Sojka et al., 2014a;  Tang et al.,
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Figure 2   Development pathway of of innate lymphoid cells (ILCs). ILCs and adaptive lymphocytes develop from CLPs, which further differentiate into
EILPs. EILPs are marked by the expression of TCF1 and can give rise to all known ILC lineages. Downstream of EILPs, Id2-expressing common helper-like
ILC progenitors (CHILPs) lose the potential to develop into the cNK cell lineage, but can give rise to all helper-like ILC subsets. Upregulation of PLZF in
CHILPs coincides with the loss of LTi cell differentiation potential but maintaining other ILC potential.
2016). Transcription factor T-bet is strictly required for the
early development of liver trNK cells, but only has moderate
effects in cNK cell development (Daussy et al., 2014; Tang et
al., 2016). Moreover, PLZF and Hobit are also respectively
required for the development of liver trNK but not cNK cells
(Constantinides et al., 2014; Mackay et al., 2016). Addition-
ally, as compared to cNK cells, liver trNK cells expressed
low levels of Eomes, which is important for cNK cell devel-
opment but does not impact liver trNK cells (Daussy et al.,
2014; Gordon et al., 2012). Thus, liver trNK cells and cNK
cells have differential transcription factor requirements.
FUNCTIONS OF LIVER TRNK CELLS
Memory-like responses mediated by liver trNK cells
Accumulating evidence has recently shown that NK cells pos-
sess certain features of immunological memory (O’Sullivan
et al., 2015). NK cells can mount recall responses following
specific activation by chemical haptens (O’Leary et al., 2006;
Paust et al., 2010) or viruses (Foley et al., 2012; Gillard et
al., 2011; Paust et al., 2010; Sun et al., 2009), or non-spe-
cific activation by cytokines (Cooper et al., 2009; Keppel et
al., 2013), respectively. The first evidence for NK cell mem-
ory came from observations that mice devoid of T cells and
B cells but possessing NK cells mediated CHS responses in
a hapten-specific manner (O’Leary et al., 2006). Of particu-
lar interest, memory-like NK cells in CHS models were un-
expectedly restricted to the liver, whereas splenic NK cells
failed to mount CHS responses (O’Leary et al., 2006; Paust
et al., 2010). Our later studies confirmed this phenomenon
and further showed that transfer of liver trNK cells could con-
fer the recall response in CHS models, but liver cNK cells
was ineffective (Peng et al., 2013). However, it remains puz-
zling how liver trNK cells exert effector functions at the site
of challenge. Another important issue to be addressed is how
NK cells recognize different antigens since they do not ex-
press RAG-dependent antigen receptors.
Potential roles of trNK cells in liver diseases
The liver is an immune tolerant organ with unique predispo-
sition for chronic infections by certain clinically important
pathogens (Fahey et al., 2014; Xu et al., 2014; Yang et al.,
2014; Zheng et al., 2014). Both pathogenic and protective
functions of NK cells in viral infections have been reported
(Jost and Altfeld, 2013; Schuch et al., 2014), but it is unclear
whether liver trNK cells and cNK cells play similar or distinct
roles in anti-viral immune responses. Like cNK cells, liver
trNK cells are cytotoxic and IFN-γ producers (Sojka et al.,
2014a). It is possible that liver trNK cells may spontaneously
lyse virus-infected hepatocytes and promote Th1 polariza-
tion via IFN-γ, thereby contributing to viral clearance in the
liver. However, trNK cells have also been found to have
immune-regulatory functions through crosstalk with other
immune cells. For example, salivary gland trNK cells, which
highly express TRAIL, eliminate activated CD4+ T cells in
a TRAIL-dependent manner and consequently delay viral
clearance during chronic murine cytomegalovirus (MCMV)
infection (Schuster et al., 2014). Liver trNK cells express
high levels of NKG2A; a recent study found that signalling
through NKG2A inhibited accumulation of IFN-γ+ cNK and
thereby limited antiviral CD8+ T cell responses (Krueger et
al., 2016), suggestive of the immune-regulatory potential of
liver trNK cells. Moreover, our previous study showed that
genes associated with immune tolerance and negative regu-
lations were upregulated in liver trNK cells as compared to
those in cNK cells. Therefore, liver trNK cells also have the
potential to negatively regulate anti-viral immune responses.
CD49A AS A COMMON MARKER FOR TRNK
CELLS
The discovery of liver trNK cells motivates the study of trNK
cells in other tissues, which provides new insights into the
heterogeneity of NK cell subsets. Recent findings have re-
vealed that trNK cells in different tissues have striking pheno-
typic features similar to those in the liver (Erick and Brossay,
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CD49a is also known as integrin α1 and can associate with
the integrin β1 subunit (CD29) to form the CD49a/CD29
(VLA-1) heterodimer, which is responsible for retaining
lymphocytes in tissues (Ray et al., 2004; Richter et al., 2007).
By parabiosis studies, CD49a was also found to be a marker
of trNK cells in other tissues. Akin to the liver, uterus, skin
and adipose contain high frequency of CD49a+DX5− trNK
cells (Richter et al., 2007; Sojka et al., 2014a). In contrast
to liver and skin trNK cells, uterus NK cells are T-bet-in-
dependent and express high levels of Eomes (Sojka et al.,
2014a; Tayade et al., 2005). Interestingly, salivary gland
NK cells are tissue-resident and exhibit positivity for both
CD49a and DX5 (Cortez et al., 2016). Unlike trNK cells in
other tissues, salivary gland NK cells are present in normal
numbers in T-bet-, Eomes-, and NFIL3-deficient mice, but
lack of TGF-β-signaling markedly reduced salivary gland
NK cell numbers (Cortez et al., 2014; Cortez et al., 2016).
In addition to CD49a, several other markers commonly
expressed by trNK cells have been reported, including CD69
and TRAIL. CD69 can antagonize sphingosine-1 phosphate
receptor 1 (S1P1) (Bankovich et al., 2010; Shiow et al.,
2006), which promotes lymphocyte egress in to blood (Zajac
and Harrington, 2014), and thus it could be relevant to the
tissue residency of non-cNK cell subsets. Similarly, other
non-recirculating lymphoid lineages, such as tissue-resident
memory T (Trm) and NKT cells, also highly express CD49a
and CD69 (Mackay et al., 2016). Moreover, Trm and NKT
cells also require Hobit for their maintenance, like liver trNK
cells (Mackay et al., 2016). Collectively, trNK cells and
other tissue-resident lymphocytes exhibit shared expression
patterns of surface markers and transcriptional factors that
instructs tissue retention.
LIVER TRNK CELLS: FROM MOUSE TO
HUMAN
In humans, liver NK cells with equal proportions of CD56bright
and CD56dim subsets can account up to 30%–40% of total
hepatic lymphocytes (Moroso et al., 2010), in contrast to
their low frequency in other tissues. Previous studies about
human liver NK cells have been mainly focused on their
roles in liver diseases including viral infections, fibrosis,
and tumors (Araujo et al., 2014; Fasbender et al., 2016;
Rehermann, 2013); however, few studies have specifically
descripted the characteristics of human liver NK cells under
homeostatic conditions. The discovery of liver trNK cells
in mice prompted researchers to further investigate whether
the human liver also contains a unique trNK cell subset. In
humans, liver CD56dim NK cell subset phenotypically and
functionally resembles peripheral blood CD56dim NK cells,
which represent at least 90% of all peripheral blood NK cells,
and thus can be regarded as cNK cells (Hudspeth et al., 2016).
In contrast to CD56dim cNK cells, hepatic CD56bright NK cells
express trNK cell markers such as CD69 and CXCR6, and
lack cNK cell markers such as CD62L and CCR7 (Burt et
al., 2009; Hudspeth et al., 2016). Moreover, human hepatic
CD56bright NK cells exhibit unique transcriptional profiles
compared to cNK cells. CCL3, CCL4, CXCL16, which are
highly expressed in the sinusoids of the healthy liver, can
selectively induce migration of hepatic CD56bright NK cells
(Hudspeth et al., 2016), hinting at a possible mechanism for
their retention in the human liver.
Similar to murine liver trNK cells, a proportion of human
hepatic CD56bright NK cells with the expression of CD49a are
T-bet+Eomes− (Marquardt et al., 2015). Interestingly, these
CD49a+ NK cells display a narrow killer cell Ig-like recep-
tor (KIR) expression pattern, suggestive of having undergone
clonal-like expansion. Inconsistent with the highly frequency
(about 50%) of murine liver trNK cells, however, human he-
patic CD49a+ NK cells are at a very low frequency (average
2.3%) and even undetectable in some cases (Marquardt et al.,
2015). Therefore, the precise identification of human liver
trNK cells remains to be further studied.
CONCLUDING REMARKS
Recent studies have indicated that the liver contains two dis-
tinct NK cell subsets: trNK cells and cNK cells. There are
substantial differences between the two subsets in terms of
phenotype, functions, and developmental requirements. The
discovery of liver trNK cells led to the investigation of trNK
cells in other tissues, which has greatly expanded our knowl-
edge of NK cell diversity. However, many new questions
concurrently arise, and the following issues need to be ad-
dressed in future studies: (i) the origin of trNK cells in dif-
ferent tissues, (ii) the local environmental factors involved in
the tissue residency and maintenance of trNK cells, (iii) con-
tribution of trNK cells in the progress of different diseases
such as infection and inflammatory diseases, (iv) molecular
mechanisms underlyingmemory-like responses by liver trNK
cells, and (v) precise identification of human trNK cells. Ad-
dressing the above questions has an enormous potential not
only to improve our knowledge on NK cell biology but also
to facilitate future clinical applications of NK cell-based im-
munotherapy.
Compliance and ethics     The author(s) declare that they have no conflict
of interest.
Acknowledgements    This work was supported by theMinistry of Science&
Technology of China (2013CB944902), and the Natural Science Foundation
of China (81361120388, 81571522, 31300727, 91542114, 91442112)
Araujo, P., Gonçalves, G., Latini, F., Ferreira, O., Porto, L.C., Barreto, J.A.,
Girao, M.J.C., and Diaz, R.S. (2014). KIR and a specificHLA-C gene are
associated with susceptibility and resistance to hepatitis B virus infection
Peng, H., et al.   Sci China Life Sci   December (2016)  Vol. 59  No. 12 1221
in a Brazilian population. Cell Mol Immunol 11, 609–612.
Bankovich, A.J., Shiow, L.R., and Cyster, J.G. (2010). CD69 suppresses
sphingosine 1-phosophate receptor-1 (S1P1) function through interaction
with membrane Helix 4. J Biol Chem 285, 22328–22337.
Burt, B.M., Plitas, G., Zhao, Z., Bamboat, Z.M., Nguyen, H.M., Dupont,
B., and DeMatteo, R.P. (2009). The lytic potential of human liver NK
cells is restricted by their limited expression of inhibitory killer Ig-like
receptors. J Immunol 183, 1789–1796.
Constantinides, M.G., McDonald, B.D., Verhoef, P.A., and Bendelac, A.
(2014). A committed precursor to innate lymphoid cells. Nature 508,
397–401.
Cooper, M.A., Elliott, J.M., Keyel, P.A., Yang, L., Carrero, J.A., and
Yokoyama, W.M. (2009). Cytokine-induced memory-like natural killer
cells. Proc Natl Acad Sci USA 106, 1915–1919.
Cortez, V.S., Cervantes-Barragan, L., Robinette, M.L., Bando, J.K., Wang,
Y., Geiger, T.L., Gilfillan, S., Fuchs, A., Vivier, E., Sun, J.C., Cella, M.,
and Colonna, M. (2016). Transforming growth factor-β signaling guides
the differentiation of innate lymphoid cells in salivary glands. Immunity
44, 1127–1139.
Cortez, V.S., Fuchs, A., Cella, M., Gilfillan, S., and Colonna, M. (2014).
Cutting edge: salivary gland NK cells develop independently of Nfil3 in
steady-state. J Immunol 192, 4487–4491.
Crosbie, O.M., Reynolds, M., McEntee, G., Traynor, O., Hegarty, J.E., and
O’Farrelly, C. (1999). In vitro evidence for the presence of hematopoietic
stem cells in the adult human liver. Hepatology 29, 1193–1198.
Crotta, S., Gkioka, A., Male, V., Duarte, J.H., Davidson, S., Nisoli, I., Brady,
H.J.M., and Wack, A. (2014). The transcription factor E4BP4 is not re-
quired for extramedullary pathways of NK cell development. J Immunol
192, 2677–2688.
Dahlberg, C.I.M., Sarhan, D., Chrobok, M., Duru, A.D., and Alici, E. (2015).
Natural killer cell-based therapies targeting cancer: possible strategies to
gain and sustain anti-tumor activity. Front Immunol 6, 605.
Daussy, C., Faure, F., Mayol, K., Viel, S., Gasteiger, G., Charrier, E.,
Bienvenu, J., Henry, T., Debien, E., Hasan, U.A., Marvel, J., Yoh, K.,
Takahashi, S., Prinz, I., de Bernard, S., Buffat, L., and Walzer, T. (2014).
T-bet and Eomes instruct the development of two distinct natural killer
cell lineages in the liver and in the bone marrow. J Exp Med 211,
563–577.
Eissens, D.N., Michelo, C.M., Preijers, F.W.M.B., van Cranenbroek, B., van
Houwelingen, K., van der Meer, A., and Joosten, I. (2014). Selective
expansion of human natural killer cells leads to enhanced alloreactivity.
Cell Mol Immunol 11, 160–168.
Erick, T.K., andBrossay, L. (2016). Phenotype and functions of conventional
and non-conventional NK cells. Curr Opin Immunol 38, 67–74.
Fahey, S., Dempsey, E., and Long, A. (2014). The role of chemokines in
acute and chronic hepatitis C infection. Cell Mol Immunol 11, 25–40.
Fasbender, F., Widera, A., Hengstler, J.G., and Watzl, C. (2016). Natural
killer cells and liver fibrosis. Front Immunol 7, 19.
Foley, B., Cooley, S., Verneris, M.R., Curtsinger, J., Luo, X., Waller,
E.K., Anasetti, C., Weisdorf, D., and Miller, J.S. (2012). Human
cytomegalovirus (CMV)-induced memory-like NKG2C+ NK cells are
transplantable and expand in vivo in response to recipient CMV antigen.
J Immunol 189, 5082–5088.
Gao, B., Jeong, W.I., and Tian, Z. (2008). Liver: an organ with predominant
innate immunity. Hepatology 47, 729–736.
Gasteiger, G., Fan, X., Dikiy, S., Lee, S.Y., and Rudensky, A.Y. (2015). Tis-
sue residency of innate lymphoid cells in lymphoid and nonlymphoid
organs. Science 350, 981–985.
Geiger, T.L., Abt, M.C., Gasteiger, G., Firth, M.A., O’Connor, M.H., Geary,
C.D., O’Sullivan, T.E., van den Brink, M.R., Pamer, E.G., Hanash, A.M.,
and Sun, J.C. (2014). Nfil3 is crucial for development of innate lymphoid
cells and host protection against intestinal pathogens. J Exp Med 211,
1723–1731.
Gillard, G.O., Bivas-Benita, M., Hovav, A.H., Grandpre, L.E., Panas, M.W.,
Seaman, M.S., Haynes, B.F., and Letvin, N.L. (2011). Thy1+ Nk cells
from vaccinia virus-primed mice confer protection against vaccinia
virus challenge in the absence of adaptive lymphocytes. PLoS Pathog
7, e1002141.
Gordon, S.M., Chaix, J., Rupp, L.J., Wu, J., Madera, S., Sun, J.C., Lindsten,
T., and Reiner, S.L. (2012). The transcription factors T-bet and eomes
control key checkpoints of natural killer cell maturation. Immunity 36,
55–67.
Hudspeth, K., Donadon, M., Cimino, M., Pontarini, E., Tentorio, P., Preti,
M., Hong, M., Bertoletti, A., Bicciato, S., Invernizzi, P., Lugli, E.,
Torzilli, G., Gershwin, M.E., and Mavilio, D. (2016). Human liver-res-
ident CD56bright/CD16neg NK cells are retained within hepatic sinusoids
via the engagement of CCR5 and CXCR6 pathways. J Autoimmun 66,
40–50.
Jenne, C.N., and Kubes, P. (2013). Immune surveillance by the liver. Nat
Immunol 14, 996–1006.
Jost, S., and Altfeld, M. (2013). Control of human viral infections by natural
killer cells. Annu Rev Immunol 31, 163–194.
Keppel, M.P., Yang, L., and Cooper, M.A. (2013). Murine NK cell intrin-
sic cytokine-induced memory-like responses are maintained following
homeostatic proliferation. J Immunol 190, 4754–4762.
Kim, S., Iizuka, K., Kang, H.S.P., Dokun, A., French, A.R., Greco, S., and
Yokoyama, W.M. (2002). In vivo developmental stages in murine natural
killer cell maturation. Nat Immunol 3, 523–528.
Klose, C.S.N., Flach, M., Möhle, L., Rogell, L., Hoyler, T., Ebert, K.,
Fabiunke, C., Pfeifer, D., Sexl, V., Fonseca-Pereira, D., Domingues,
R.G., Veiga-Fernandes, H., Arnold, S.J., Busslinger, M., Dunay, I.R.,
Tanriver, Y., and Diefenbach, A. (2014). Differentiation of type 1
ILCs from a common progenitor to all helper-like innate lymphoid cell
lineages. Cell 157, 340–356.
Kotton, D.N., Fabian, A.J., and Mulligan, R.C. (2005). A novel stem-cell
population in adult liver with potent hematopoietic-reconstitution activ-
ity. Blood 106, 1574–1580.
Krueger, P.D., Narayanan, S., Surette, F.A., Brown, M.G., Sung, S.S.J., and
Hahn, Y.S. (2016). Murine liver-resident group 1 innate lymphoid cells
regulate optimal priming of anti-viral CD8+ T cells. J Leukocyte Biol in
press, doi: 10.1189/jlb.3A0516-225R.
Ma, Z., Zhang, E., Yang, D., and Lu, M. (2015). Contribution of Toll-like
receptors to the control of hepatitis B virus infection by initiating antivi-
ral innate responses and promoting specific adaptive immune responses.
Cell Mol Immunol 12, 273–282.
Mackay, L.K., Minnich, M., Kragten, N.A.M., Liao, Y., Nota, B., Seillet, C.,
Zaid, A., Man, K., Preston, S., Freestone, D., Braun, A., Wynne-Jones,
E., Behr, F.M., Stark, R., Pellicci, D.G., Godfrey, D.I., Belz, G.T.,
Pellegrini, M., Gebhardt, T., Busslinger, M., Shi, W., Carbone, F.R.,
van Lier, R.A.W., Kallies, A., and van Gisbergen, K.P.J.M. (2016).
Hobit and Blimp1 instruct a universal transcriptional program of tissue
residency in lymphocytes. Science 352, 459–463.
Marquardt, N., Béziat, V., Nyström, S., Hengst, J., Ivarsson, M.A.,
Kekäläinen, E., Johansson, H., Mjösberg, J., Westgren, M., Lankisch,
T.O., Wedemeyer, H., Ellis, E.C., Ljunggren, H.G., Michaëlsson, J., and
Björkström, N.K. (2015). Cutting edge: identification and characteriza-
tion of human intrahepatic CD49a+ NK cells. JI 194, 2467–2471.
Moroso, V., Metselaar, H.J., Mancham, S., Tilanus, H.W., Eissens, D.,
van der Meer, A., van der Laan, L.J.W., Kuipers, E.J., Joosten, I.,
and Kwekkeboom, J. (2010). Liver grafts contain a unique subset
of natural killer cells that are transferred into the recipient after liver
transplantation. Liver Transpl 16, 895–908.
O’Leary, J.G., Goodarzi, M., Drayton, D.L., and von Andrian, U.H. (2006).
T cell- and B cell-independent adaptive immunity mediated by natural
killer cells. Nat Immunol 7, 507–516.
O’Sullivan, T.E., Sun, J.C., and Lanier, L.L. (2015). Natural killer cell mem-
ory. Immunity 43, 634–645.
Orkin, S.H., and Zon, L.I. (2008). Hematopoiesis: an evolving paradigm for
stem cell biology. Cell 132, 631–644.
Paust, S., Gill, H.S., Wang, B.Z., Flynn, M.P., Moseman, E.A., Senman, B.,
Szczepanik, M., Telenti, A., Askenase, P.W., Compans, R.W., and von
Andrian, U.H. (2010). Critical role for the chemokine receptor CXCR6
1222 Peng, H., et al.   Sci China Life Sci   December (2016)  Vol. 59  No. 12
in NK cell-mediated antigen-specific memory of haptens and viruses.
Nat Immunol 11, 1127–1135.
Peng, H., Jiang, X., Chen, Y., Sojka, D.K., Wei, H., Gao, X., Sun, R.,
Yokoyama, W.M., and Tian, Z. (2013). Liver-resident NK cells con-
fer adaptive immunity in skin-contact inflammation. J Clin Invest 123,
1444–1456.
Peng, H., and Tian, Z. (2015). Re-examining the origin and function of liver-
resident NK cells. Trends Immunol 36, 293–299.
Racanelli, V., and Rehermann, B. (2006). The liver as an immunological
organ. Hepatology 43, S54–S62.
Rajagopalan, S. (2014). HLA-G-mediatedNK cell senescence promotes vas-
cular remodeling: implications for reproduction. Cell Mol Immunol 11,
460–466.
Ray, S.J., Franki, S.N., Pierce, R.H., Dimitrova, S., Koteliansky, V., Sprague,
A.G., Doherty, P.C., de Fougerolles, A.R., and Topham, D.J. (2004). The
collagen binding α1β1 integrin VLA-1 regulates CD8 T cell-mediated
immune protection against heterologous influenza infection. Immunity
20, 167–179.
Rehermann, B. (2013). Pathogenesis of chronic viral hepatitis: differential
roles of T cells and NK cells. Nat Med 19, 859–868.
Richter, M., Ray, S.J., Chapman, T.J., Austin, S.J., Rebhahn, J., Mosmann,
T.R., Gardner, H., Kotelianski, V., deFougerolles, A.R., and Topham,
D.J. (2007). Collagen distribution and expression of collagen-binding
α1β1 (VLA-1) and α2β1 (VLA-2) integrins on CD4 and CD8 T cells
during influenza infection. J Immunol 178, 4506–4516.
Schuch, A., Hoh, A., and Thimme, R. (2014). The role of natural killer cells
and CD8+ T cells in hepatitis B virus infection. Front Immunol 5, 258.
Schuster, I.S., Wikstrom, M.E., Brizard, G., Coudert, J.D., Estcourt, M.J.,
Manzur, M., O’Reilly, L.A., Smyth, M.J., Trapani, J.A., Hill, G.R.,
Andoniou, C.E., and Degli-Esposti, M.A. (2014). TRAIL+ NK cells
control CD4+ T cell responses during chronic viral infection to limit
autoimmunity. Immunity 41, 646–656.
Seillet, C., Huntington, N.D., Gangatirkar, P., Axelsson, E., Minnich, M.,
Brady, H.J.M., Busslinger, M., Smyth, M.J., Belz, G.T., and Carotta, S.
(2014a). Differential requirement for Nfil3 during NK cell development.
J Immunol 192, 2667–2676.
Seillet, C., Rankin, L.C., Groom, J.R., Mielke, L.A., Tellier, J., Chopin, M.,
Huntington, N.D., Belz, G.T., and Carotta, S. (2014b). Nfil3 is required
for the development of all innate lymphoid cell subsets. J Exp Med 211,
1733–1740.
Shi, F.D., Ljunggren, H.G., La Cava, A., and Van Kaer, L. (2011). Organ-
specific features of natural killer cells. Nat Rev Immunol 11, 658–671.
Shiow, L.R., Rosen, D.B., Brdicková, N., Xu, Y., An, J., Lanier, L.L., Cyster,
J.G., and Matloubian, M. (2006). CD69 acts downstream of interferon-
α/β to inhibit S1P1 and lymphocyte egress from lymphoid organs. Nature
440, 540–544.
Sojka, D.K., Plougastel-Douglas, B., Yang, L., Pak-Wittel, M.A., Artyomov,
M.N., Ivanova, Y., Zhong, C., Chase, J.M., Rothman, P.B., Yu, J., Riley,
J.K., Zhu, J., Tian, Z., and Yokoyama, W.M. (2014a). Tissue-resident
natural killer (NK) cells are cell lineages distinct from thymic and con-
ventional splenic NK cells. eLife 3, e01659.
Sojka, D.K., Tian, Z., and Yokoyama, W.M. (2014b). Tissue-resident natural
killer cells and their potential diversity. Semin Immunol 26, 127–131.
Spits, H., andDi Santo, J.P. (2011). The expanding family of innate lymphoid
cells: regulators and effectors of immunity and tissue remodeling. Nat
Immunol 12, 21–27.
Sun, C., Sun, H., Zhang, C., and Tian, Z. (2015). NK cell receptor imbalance
and NK cell dysfunction in HBV infection and hepatocellular carcinoma.
Cell Mol Immunol 12, 292–302.
Sun, J.C., Beilke, J.N., and Lanier, L.L. (2009). Adaptive immune features
of natural killer cells. Nature 457, 557–561.
Takeda, K., Cretney, E., Hayakawa, Y., Ota, T., Akiba, H., Ogasawara, K.,
Yagita, H., Kinoshita, K., Okumura, K., and Smyth, M.J. (2005). TRAIL
identifies immature natural killer cells in newborn mice and adult mouse
liver. Blood 105, 2082–2089.
Tang, L., Peng, H., Zhou, J., Chen, Y., Wei, H., Sun, R., Yokoyama, W.M.,
and Tian, Z. (2016). Differential phenotypic and functional properties of
liver-resident NK cells and mucosal ILC1s. J Autoimmun 67, 29–35.
Taniguchi, H., Toyoshima, T., Fukao, K., and Nakauchi, H. (1996). Presence
of hematopoietic stem cells in the adult liver. Nat Med 2, 198–203.
Tayade, C., Fang, Y., Black, G.P., V A, P., Erlebacher, A., and Croy, B.A.
(2005). Differential transcription of Eomes and T-bet during maturation
of mouse uterine natural killer cells. J Leukocyte Biol 78, 1347–1355.
Wang, X.Q., Lo, C.M., Chen, L., Cheung, C.K.Y., Yang, Z.F., Chen, Y.X.,
Ng, M.N., Yu, W.C., Ming, X., Zhang, W., Ho, D.W.Y., Chan, S.C.,
and Fan, S.T. (2012). Hematopoietic chimerism in liver transplantation
patients and hematopoietic stem/progenitor cells in adult human liver.
Hepatology 56, 1557–1566.
Xu, R., Huang, H., Zhang, Z., andWang, F.S. (2014). The role of neutrophils
in the development of liver diseases. Cell Mol Immunol 11, 224–231.
Yang, D., Liu, L., Zhu, D., Peng, H., Su, L., Fu, Y.X., and Zhang, L. (2014).
A mouse model for HBV immunotolerance and immunotherapy. Cell
Mol Immunol 11, 71–78.
Yang, Q., Li, F., Harly, C., Xing, S., Ye, L., Xia, X., Wang, H., Wang, X., Yu,
S., Zhou, X., Cam, M., Xue, H.H., and Bhandoola, A. (2015). TCF-1 up-
regulation identifies early innate lymphoid progenitors in the bone mar-
row. Nat Immunol 16, 1044–1050.
Yokoyama, W.M., Sojka, D.K., Peng, H., and Tian, Z. (2013). Tissue-resi-
dent natural killer cells. Cold SpringHarb SympQuant Biol 78, 149–156.
Yu, X., Wang, Y., Deng, M., Li, Y., Ruhn, K.A., Zhang, C.C., and Hooper,
L.V. (2014). The basic leucine zipper transcription factor NFIL3 directs
the development of a common innate lymphoid cell precursor. eLife 3,
e04406.
Zajac, A.J., and Harrington, L.E. (2014). Tissue-resident T cells lose their
S1P1 exit visas. Cell Mol Immunol 11, 221–223.
Zheng, J., Liang, H., Xu, C., Xu, Q., Zhang, T., Shen, T., and Lu, F. (2014).
An unbalanced PD-L1/CD86 ratio in CD14++CD16+ monocytes is cor-
related with HCV viremia during chronic HCV infection. Cell Mol Im-
munol 11, 294–304.
Zook, E.C., and Kee, B.L. (2016). Development of innate lymphoid cells.
Nat Immunol 17, 775–782.
Open Access    This article is distributed under the terms of the Creative Commons Attribution License which permits any use, distribution, and reproduction
in any medium, provided the original author(s) and source are credited.
Peng, H., et al.   Sci China Life Sci   December (2016)  Vol. 59  No. 12 1223
